Differences in protein binding and excretion of Triapine and its Fe(III) complex-Reference-Cited by-同舟云学术

Differences in protein binding and excretion of Triapine and its Fe(III) complex

Published:2016-07 Issue: Volume:160 Page:61-69
ISSN:0162-0134
Container-title:Journal of Inorganic Biochemistry
language:en
Short-container-title:Journal of Inorganic Biochemistry

Author:

Pelivan Karla,Miklos Walter,van Schoonhoven Sushilla,Koellensperger Gunda,Gille Lars,Berger Walter,Heffeter Petra,Kowol Christian R.,Keppler Bernhard K.

Funder

Austrian Science Fund (FWF)

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Biochemistry

Reference38 articles.

1. Chelators at the Cancer Coalface: Desferrioxamine to Triapine and Beyond

2. Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents

3. Phase I and pharmacodynamic study of Triapine®, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia

4. Targeting cancer by binding iron: Dissecting cellular signaling pathways

5. Mechanistic Studies of Semicarbazone Triapine Targeting Human Ribonucleotide Reductase in Vitro and in Mammalian Cells

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3-AP inhibits the growth of human osteosarcoma by decreasing the activity of the iron-dependent pathway;Medical Oncology;2023-11-11

2. Structural and Functional Diversity in Rigid Thiosemicarbazones with Extended Aromatic Frameworks: Microwave-Assisted Synthesis and Structural Investigations;ACS Omega;2023-04-25

3. Thiosemicarbazone Derivatives Developed to Overcome COTI-2 Resistance;Cancers;2022-09-14

4. Ruthenium-based antitumor drugs and delivery systems from monotherapy to combination therapy;Nanoscale;2022

5. Liposomal formulations of anticancer copper(ii) thiosemicarbazone complexes;Dalton Transactions;2021